Hemoximer Pyridoxalated hemoglobin polyoxyethylene: Phase III started

Curacyte began the placebo-controlled, European Phase III Phoenix trial to evaluate 0.25 ml/kg/hr PHP given as a continuous IV infusion in more than 450 patients unresponsive to standard therapy with ...